8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)
Published . Updated .
8-K - VERTEX PHARMACEUTICALS / MA filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- VRTX Vertex Pharmaceuticals Inc / Ma+9.5% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VRTX | -5.88% | -2.43% | base | after close | after close | after close | after close |
| XLV | -3.14% | -0.51% | base | after close | after close | after close | after close |
| XBI | +1.64% | +3.59% | base | after close | after close | after close | after close |
| LLY | -9.70% | -3.22% | base | after close | after close | after close | after close |
| JNJ | -1.08% | +1.28% | base | after close | after close | after close | after close |
| PFE | -3.81% | -3.29% | base | after close | after close | after close | after close |
| MRK | -4.78% | -1.78% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0000875320-26-000287 Size: 447 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 2 Nov 2026: Vertex Pharmaceuticals Inc / Ma (VRTX) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | +1.28% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.08% | final price |
| Eli Lilly (LLY) | three days earlier | -3.22% | final price |
| Eli Lilly (LLY) | five days earlier | -9.70% | final price |
| Merck (MRK) | three days earlier | -1.78% | final price |
| Merck (MRK) | five days earlier | -4.78% | final price |
| Pfizer (PFE) | three days earlier | -3.29% | final price |
| Pfizer (PFE) | five days earlier | -3.81% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | three days earlier | -2.43% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | five days earlier | -5.88% | final price |
| Spdr Series Trust (XBI) | three days earlier | +3.59% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.64% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.51% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.14% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Vertex Pharmaceuticals Inc / Ma (VRTX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. David J. Taylor sold Vertex Pharmaceuticals Inc / Ma (VRTX), worth $1,001 - $15,000 on 26 Aug 2026. That is 68 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Vertex Pharmaceuticals Inc / Ma (VRTX)
Companies mentioned with this story
- VRTX Vertex Pharmaceuticals Inc / Ma
In “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Vertex Pharmaceuticals Inc / Ma (VRTX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VRTX
- XLV Select Sector Spdr Tr
For “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
In “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
For “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
For “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
Pfizer (PFE) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer).” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
In “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” reaches Vertex Pharmaceuticals Inc / Ma (VRTX)
On 2 Nov 2026, “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” is the story that connects Vertex Pharmaceuticals Inc / Ma (VRTX) to this story.
For Vertex Pharmaceuticals Inc / Ma (VRTX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> VRTX
Select Sector Spdr Tr (XLV) is here too. Its reason reads: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Dates in the story, and the Vertex Pharmaceuticals Inc / Ma (VRTX) price range
VRTX traded between 484.86 and 563.00 across 20 sessions. The latest close on file is 559.04.
What the saved facts support for Vertex Pharmaceuticals Inc / Ma (VRTX)
46 out of 100
“8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.